Zurcher Kantonalbank Zurich Cantonalbank Purchases 30,402 Shares of Humana Inc. $HUM

Zurcher Kantonalbank Zurich Cantonalbank raised its position in Humana Inc. (NYSE:HUM) by 56.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 84,695 shares of the insurance provider’s stock after acquiring an additional 30,402 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Humana were worth $21,693,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of HUM. CoreCap Advisors LLC lifted its holdings in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the period. Rosenberg Matthew Hamilton lifted its holdings in Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the period. Mather Group LLC. bought a new position in Humana in the third quarter valued at about $34,000. Private Wealth Management Group LLC lifted its holdings in Humana by 47.5% in the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 48 shares during the period. Finally, Larson Financial Group LLC increased its position in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after buying an additional 81 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the subject of a number of analyst reports. Barclays reduced their price target on Humana from $245.00 to $176.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 24th. Deutsche Bank Aktiengesellschaft set a $180.00 price target on Humana and gave the stock a “hold” rating in a research report on Friday, February 13th. UBS Group restated a “neutral” rating on shares of Humana in a research report on Wednesday, February 25th. Oppenheimer set a $250.00 price target on Humana in a research report on Thursday, February 12th. Finally, Evercore upped their price target on Humana from $180.00 to $195.00 in a research report on Wednesday, April 8th. Seven equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, Humana has a consensus rating of “Hold” and an average price target of $222.09.

Humana Stock Performance

NYSE HUM opened at $217.84 on Wednesday. The stock has a market capitalization of $26.15 billion, a PE ratio of 22.18, a P/E/G ratio of 2.25 and a beta of 0.44. The business has a 50 day simple moving average of $182.46 and a two-hundred day simple moving average of $229.86. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.00. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $315.35.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, beating the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The firm’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter last year, the business posted ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, research analysts predict that Humana Inc. will post 9.05 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.6%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is currently 36.05%.

Insiders Place Their Bets

In other news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was acquired at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the acquisition, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This represents a 7.47% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.20% of the stock is owned by corporate insiders.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.